Trending News: Scientists Are Testing How To Regenerate The Brains Of Dead People
Why Is This Important?
Because nothing bad could ever come of bringing the dead back to life. Right?
Health watchdogs in the US have approved a biotech’s company plan to test the brains of 20 people declared clinically dead to see if they can be reanimated.
More scientific than Melisandre and less dramatic than The Walking Dead, Bioquark Inc. plans to inject stem cells and a mix of peptides, as well as using laser technology and nerve stimulation, to see if they can bring parts of the central nervous system in their subjects back to life.
The 20 patients will have to have been declared clinically brain dead and only kept "alive" through life support. They will be monitored using brain imaging technology as peptides are administered daily into their spinal cords via a pump, while the stem cells will be injected bi-weekly over a six-week span.
“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime,” says Bioquark’s CEO Dr. Ira Pastor.
The US National Institute of Health just approved the ReAnima Project, and the company will be recruiting its first 20 patients immediately. The first stage, called “First In Human Neuro-Regeneration & Neuro-Reanimation,” will take place at a hospital in India. The patients will be screened to see if there are any religious or medical issues with organ donation.
The researchers are hoping their treatment can repair severely damaged central nervous systems — something that is impossible in nature for humans, but has been seen in certain types of fish and amphibians.
“Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma, and the vegetative and minimally conscious states, as well as a range of degenerative CNS conditions, including Alzheimer's and Parkinson's disease,” says Bioquark’s founder, president and chief science officer Dr. Sergei Paylian.
The company hopes to see results within two to three months.
Blogger Comment
Facebook Comment